<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Alcon on its USD 600 million acquisition of ESBATech Inc., Switzerland | Pestalozzi Attorneys at Law

Pestalozzi advised Alcon on its USD 600 million acquisition of ESBATech Inc., Switzerland

01.09.2009

Alcon entered into a definitive agreement to acquire ESBATech AG, a Swiss biotechnology company. Alcon will pay ESBATech shareholders USD 150 million in cash at closing, plus contingent payments of up to USD 439 million based upon the achievement of future research and development milestones that would be expected to create value for Alcon. Pestalozzi acted as counsel to Alcon.

To the top

Cookies

Close
We use cookies in order to optimally design and continuously improve our website. By continuing to use the website you consent to the use of cookies. For further information about cookies please view our data protection statement.